Our in silico analysis supported an association of HSPB7 with various human cardiovascular pathologies, most notably downregulation associated with various cardiomyopathies, heart failure and atrial fibrillation, and upregulation associated with dilated cardiomyopathy. This evidence concerns the gene HSPB7 and dilated cardiomyopathy.